About 100 reports

  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H2 2017
  • PTX-15 - DRUG PROFILE

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Targeted Therapy
  • Transplantation
  • Astellas Pharma Inc.
  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H1 2018
  • HEART TRANSPLANT REJECTION - PIPELINE BY NOXXON PHARMA AG, H1 2018

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • Target
  • Target

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION

  • Acute Coronary Syndrome
  • Clinical Trial
  • Heart Transplant
  • Targeted Therapy
  • Novartis AG

WE ARE FULFILLING OUR PROMISE TO MAKE SEQUENCING BASED INFORMATION AVAILABLE TO THE TRANSPLANT CLINIC, NOW ALSO FOR HEART TRANSPLANT PATIENTS. "

  • Orthopedics
  • Canada
  • North America
  • Market Size
  • Stryker Corporation

Food and Drug Administration (FDA), World Health Organization (WHO), GLOBOCAN, and various organ transplant registries.

  • Medical Device
  • Orthopedics
  • North America
  • United States
  • Zimmer Biomet Holdings, Inc.
  • DORMANT PRODUCTS, H2 2018 (CONTD..1), H2 2018

## ## ## Universities/ Institutes ## ## ## ## ## ## PRODUCTS UNDER DEVELOPMENT BY INDICATION NUMBER OF PRODUCTS UNDER DEVELOPMENT BY TOP ## INDICATIONS, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H## 2018 Indication Source: Global Markets Dire

  • Immunotherapy
  • Monoclonal Antibody
  • Oncology
  • Targeted Therapy
  • Apexigen, Inc.

The prominent features of this report are - ##.

  • Acute Coronary Syndrome
  • Medical Biotechnology
  • Pharmaceutical
  • Targeted Therapy
  • World

CLINICAL TRIALS BY PHASE IN G## COUNTRIES LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Clinical Trial
  • Lung Transplant
  • Monoclonal Antibody
  • Targeted Therapy
  • Novartis AG

The prominent features of this report are - ##.

  • Clinical Trial
  • Targeted Therapy
  • World
  • Product Initiative
  • Conatus Pharmaceuticals Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Autoimmune Disease
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Acute Coronary Syndrome
  • Clinical Trial
  • Ophthalmology
  • Targeted Therapy
  • Novartis AG
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2019 (CONTD..4), H1 2019
  • DORMANT PRODUCTS, H1 2019 (CONTD..1), H1 2019

MP## is currently in phase ##.

  • Immunotherapy
  • Targeted Therapy
  • World
  • Product Initiative
  • Apexigen, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Medical Biotechnology
  • Neurological Disorder
  • Targeted Therapy
  • World
  • Product Initiative

Reddy' s Under Fasting Conditions GDCT## NCT##, BA## Immunology Heart Transplant Rejection, Kidney Transplant Rejection, Liver Transplant Rejection Completed Phase I Interventional tacrolimus Dr.

  • Acute Coronary Syndrome
  • Clinical Trial
  • Immunology
  • Targeted Therapy
  • Novartis AG
  • DORMANT PRODUCTS, H2 2019 (CONTD..1), H2 2019

## Total ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT BY STAGE OF DEVELOPMENT, H## 2019 Stage of Development Number of Products Under Development PRODUCTS UNDER DEVELO

  • Immunotherapy
  • Monoclonal Antibody
  • Oncology
  • Targeted Therapy
  • Apexigen, Inc.

GDCT ID is the unique ID of GlobalData' s Pharma Intelligence Center clinical trial database Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Biomarker(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor

  • Endocrine Disease
  • Orthopedics
  • Pharmaceutical
  • Targeted Therapy
  • World
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Targeted Therapy
  • Therapy
  • World
  • Product Initiative
  • Novartis AG

Significant survival advantages for the abatacept group were demonstrated at one-year post-transplant.

  • Arthritis
  • Immunotherapy
  • Targeted Therapy
  • Therapy
  • Bristol-Myers Squibb Company

Reddy' s Under Fasting Conditions GDCT## NCT##, BA## Immunology Heart Transplant Rejection, Kidney Transplant Rejection, Liver Transplant Rejection Completed Phase I Interventional tacrolimus Dr.

  • Acute Coronary Syndrome
  • Clinical Trial
  • Liver Transplant
  • Targeted Therapy
  • Novartis AG

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## Alexion Pharmaceuticals Inc ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## Cytokinetics Inc ## ## ## ## ## ## ## Quintiles IMS Holdings Inc ## ## ## ## ## ## ## CuraVac Inc ## ## ## ## ## ## ## CSL Ltd ##

  • Acute Coronary Syndrome
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Development
  • Targeted Therapy
  • World
  • Product Initiative

Hoffmann-La Roche Ltd ## ## ## ## ## ## Clinical Research and Biosciences India Private Limited (Inactive) ## ## ## ## ## ## ClinAssess GmbH ## ## ## ## ## ## Bavarian Nordic A/ S ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## APT

  • Medical Biotechnology
  • Pharmaceutical
  • Targeted Therapy
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd arGEN-X BV ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Applied BioMath LLC ## ## ## ## ## Amgen Inc ## ## ## ## ## Almirall SA Source: GlobalData' s Pharma Intelligence C

  • Autoimmune Disease
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Acute Coronary Syndrome
  • Blood Disease
  • Clinical Trial
  • Targeted Therapy
  • Novartis AG
  • 5. All the trials included are unique trials.
  • Clinical Trial Profile Snapshots

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Acute Coronary Syndrome
  • General Medicine And Specialty Medicine
  • Targeted Therapy
  • United States
  • World
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Acute Coronary Syndrome
  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • World

## ## ## ## ## ## Pfizer Inc Stealth BioTherapeutics Inc Prolong Pharmaceuticals LLC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Minapharm Pharmaceuticals & Chemical Industries ## ## ## ## ## ## ## Merck & Co Inc ## ##

  • Acute Coronary Syndrome
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## Pharmaceutical Product Development LLC ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## MallInckrodt Plc ## ## ## ## ## ## CSL Ltd ## ## ## ## ##

  • Autoimmune Disease
  • Pharmaceutical
  • Targeted Therapy
  • Therapy
  • Novartis AG

An Open Labelled Randomized Everolimus Vs Calcineurin Inhibitors Multicenter Trial (CERTICOEUR) A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients.

  • Clinical Trial
  • Skin Cancer
  • Targeted Therapy
  • World
  • Product Initiative

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Biogen Inc Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2018 2018 trials are taken as

  • Hormone
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.